Prevention of malaria during pregnancy in West Africa: policy change and the power of subregional action

Tropical Medicine and International Health - Tập 11 Số 4 - Trang 462-469 - 2006
Robert D. Newman1, Allisyn C. Moran2, Kassoum Kayentao3, Elizabeth Benga‐De4, Mathias Yameogo5, Oumar Gaye6, Ousmane Faye7, Youssoufa Lo8, Philippe Marc Moreira7, Ogobara K. Doumbo3, Monica E. Parise1, Richard W. Steketee1
1Malaria Branch, Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
2Maternal and Neonatal Health Program, JHPIEGO Corporation, Baltimore, MD, USA
3Department of Epidemiology and Parasitic Diseases, Faculty of Medicine and Dentistry, Malaria Research and Training Centre, University of Bamako, Mali
4United States Agency for International Development Mission to Senegal, Dakar, Senegal
5Santé Maternelle et Neonatale, Koupéla, Burkina Faso
6Department of Parasitology, Faculty of Medicine, University Cheikh Anta DIOP, Dakar, Senegal
7Senegal Maternal Health and Family Planning Project, Management Sciences for Health, Dakar, Senegal
8BASICS II Project, Dakar, Senegal

Tóm tắt

SummaryBackground  Despite a broadening consensus about the effectiveness of intermittent preventive treatment (IPTp) in preventing the adverse outcomes of malaria during pregnancy, policy change to IPTp was initially limited to East Africa. In West Africa, where the policy change process for the prevention of malaria during pregnancy started much later, IPTp has been taken up swiftly.Objective  To describe the factors that contributed to the rapid adoption of policies to prevent malaria during pregnancy in West Africa.Results and Conclusion  Several factors appear to have accelerated the process: (1) recognition of the extent of the problem of malaria during pregnancy and its adverse consequences; (2) a clear, evidence‐based program strategy strongly articulated by an important multilateral organization (World Health Organization); (3) subregionally generated evidence to support the proposed strategy; (4) a subregional forum for dissemination of data and discussion regarding the proposed policy changes; (5) widespread availability of the proposed intervention drug (sulfadoxine–pyrimethamine); (6) technical support from reputable and respected institutions in drafting new policies and planning for implementation; (7) donor support for pilot experiences in integrating proposed policy change into a package of preventive services; and (8) financial support for scaling up the proposed interventions.

Từ khóa


Tài liệu tham khảo

10.4269/ajtmh.2001.64.36

10.1016/0035-9203(90)90011-3

10.1086/426400

10.1093/heapol/18.1.18

10.1056/NEJM198501103120204

10.1016/S0277-9536(02)00373-8

10.4269/ajtmh.1998.59.813

10.1093/heapol/17.2.196

10.4269/ajtmh.1994.51.515

10.1016/S0140-6736(98)07318-8

10.1086/375077

Steketee RW, 2001, The burden of malaria in pregnancy in malaria‐endemic areas, American Journal of Tropical Medicine and Hygiene, 64, 28, 10.4269/ajtmh.2001.64.28

Steketee RW, 1996, Developing effective strategies for malaria prevention programs for pregnant African women, American Journal of Tropical Medicine and Hygiene, 55, 95, 10.4269/ajtmh.1996.55.95

Walt G, 1994, Health Policy: An introduction to process and power

WHO, 1986, WHO Expert Committee on Malaria, Eighteenth Report

WHO, 2000, WHO Expert Committee on Malaria, 20th Report

WHO, 2001, The Use of Antimalarial Drugs: Report of a WHO Informal Consultation

WHO, 2004, A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region

10.1093/heapol/czh051